Epizyme News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.07.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION (PR Newswire)
06.07.22	INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ZEN, USAK, EPZM (PR Newswire)
27.06.22	Ipsen To Acquire Epizyme For $1.45/share In Cash - Quick Facts (RTTNews)
02.02.22	Pre-market Movers: MDJH, ELMS, EXC, PYPL, PHAR… (RTTNews)
27.01.22	Pre-market Movers: NSEC, EPZM, FAMI, TER, LC… (RTTNews)
27.01.22	Epizyme Prices 56.66 Mln Share Offering At $1.50/shr (RTTNews)
11.12.21	Epizyme : Preclinical Data Shows Its SETD2 Inhibitor EZM0414 Reduced Growth Of MM & DLBCL Cell Lines (RTTNews)
09.08.21	Epizyme, Hutchmed Collaborate To Develop And Commercialize Tazverik In Greater China (RTTNews)
06.11.20	Stock Alert: Epizyme Plunges Following Q3 Results (RTTNews)
19.06.20	FDA Nod For EPZM, RARE, Court Rules In MYL's Favor, Ocuphire To Hop Onto Nasdaq, ALPN Soars (RTTNews)
26.05.20	Biotech Stocks Facing FDA Decision In June 2020 (RTTNews)
14.02.20	Stock Alert: Epizyme (EPZM) (RTTNews)
21.01.20	What Awaits Epizyme (EPZM), Aimmune Therapeutics (AIMT) This Week? (RTTNews)
31.12.19	Biotech Stocks Facing FDA Decision In January 2020 (RTTNews)
08.12.19	At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK... (RTTNews)
22.10.18	Week Ahead In Pharmaceuticals: 11 Stocks To Watch (MRTX, EPZM, ITCI...) (RTTNews)
10.10.18	Epizyme - What's Next? (RTTNews)
03.10.18	Epizyme Under Pressure After Pricing Public Stock Offering (RTTNews)
25.09.18	FDA Nod For VSTM, ANAB Breathes Easy, GEMP Trims Workforce By 33% (RTTNews)
24.09.18	Epizyme: FDA Lifts Partial Clinical Hold On Tazemetostat Clinical Program (RTTNews)
03.08.18	Reshape Not In Shape, Fortress Biotech Crumbles, MZOR Down But Not Out (RTTNews)
04.06.18	FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early (RTTNews)
24.04.18	PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA (RTTNews)
11.01.18	NVAX Turns Heads, EPZM On The Rise, TTOO Already Up 25%, GBT Hits Record High (RTTNews)
14.12.17	The Outdoor Foundation Names Lise Aangeenbrug as New Executive Director (PR Newswire)
22.09.17	Versartis Loses VELOCITY - What Other Pharma Stocks Made News This Week? (RTTNews)
20.09.17	CAPR Is Hot, VBLT In Rally Mode, MYOK's Data Heartening, MediWound Bleeds (RTTNews)
14.09.17	Biotech Sector Looking to Outperform in 2017 (PR Newswire)
14.09.17	TTOO Catches Investors' Eyes, SIEN Shaping Up, AGTC Slips Into Red (RTTNews)
24.08.17	Goodwill® Executive Development Program Recognized With National Award (PR Newswire)
17.08.17	Leading Biotech Companies Receiving Orphan Drug Designation in 2017 (PR Newswire)
17.08.17	Leading Biotech Companies Receiving Orphan Drug Designation in 2017 (PR Newswire)
31.07.17	Biotech Stock Performance Review -- Celgene, Cempra, Editas Medicine, and Epizyme (PR Newswire)
28.07.17	Top Companies Receiving Orphan Drug Designation in 2017 (PR Newswire)
28.07.17	Top Companies Receiving Orphan Drug Designation in 2017 (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
15.06.17	Expansion of Global Clinical Trials for Treating an Array of Rare Diseases Boosting Market Growth (PR Newswire)
15.06.17	Expansion of Global Clinical Trials for Treating an Array of Rare Diseases Boosting Market Growth (PR Newswire)
15.06.17	ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar (RTTNews)
15.06.17	Gainers & Losers Of June 14: OMER, EPZM, ALXN, SBBP, GBT... (RTTNews)
26.04.17	AKBA Jumps On Otsuka Deal, MNOV Abuzz, CAPR Counting On HOPE... (RTTNews)
11.04.17	Research Reports Initiation on Biotech Stocks -- Epizyme, Sierra Oncology, Five Prime Therapeutics, and AveXis (PR Newswire)
28.03.17	Advocates to Storm Columbus to Request Resources to Help Fight Suicide (PR Newswire)
28.02.17	Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS... (RTTNews)
20.06.16	CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017 (RTTNews)
19.06.16	Epizyme Reports Data From Phase 2 Trial Of Tazemetostat In Non-Hodgkin Lymphoma (RTTNews)
26.09.15	Epizyme Announces Updated Tazemetostat Phase 1 Data (RTTNews)
10.07.15	ADMS At Ease, AQXP Pounded, BONE Gains Strength, Urologix Deregistered (RTTNews)
20.06.15	Epizyme Reports Positive Data From Ongoing Phase 1 Study Of Tazemetostat (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Novartis	95.58	1.90 %	K V
Logitech Intl	91.48	1.35 %	K V
Part Grp Hldg	1’393.00	1.20 %	K V
Roche Hldg G	286.00	0.28 %	K V
Sonova Hldg	319.20	0.16 %	K V
Swiss Re	139.40	-0.50 %	K V
Zurich Insur Gr	553.80	-0.54 %	K V
Kuehne+Nagel Int	207.60	-0.76 %	K V
Lonza Grp	582.00	-1.49 %	K V
Nestle	77.48	-1.53 %	K V

Nachrichten zu Epizyme Inc

Aktien Top/Flop

Meistgelesene Nachrichten